KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.61 $7.24 Friday, 26th Apr 2024 AFMD stock ended at $5.03. This is 3.07% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.35% from a day low at $4.88 to a day high of $5.19.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Mar 29, 2021 $77.60 $77.90 $73.10 $73.20 101 525
Mar 26, 2021 $80.00 $80.60 $74.90 $77.70 120 305
Mar 25, 2021 $78.50 $80.50 $76.00 $79.75 107 761
Mar 24, 2021 $83.40 $84.00 $77.09 $77.80 128 494
Mar 23, 2021 $84.00 $84.10 $79.00 $80.40 162 449
Mar 22, 2021 $83.20 $86.00 $81.70 $84.80 145 849
Mar 19, 2021 $81.50 $85.20 $80.80 $83.20 449 669
Mar 18, 2021 $82.50 $84.10 $79.50 $80.60 137 462
Mar 17, 2021 $80.24 $84.90 $80.00 $83.80 159 581
Mar 16, 2021 $73.50 $85.80 $73.35 $83.40 466 917
Mar 15, 2021 $73.30 $75.38 $71.90 $73.40 134 271
Mar 12, 2021 $73.70 $75.90 $72.50 $73.30 183 842
Mar 11, 2021 $67.20 $77.25 $67.00 $75.40 481 464
Mar 10, 2021 $62.50 $73.50 $61.10 $67.70 687 060
Mar 09, 2021 $52.80 $55.80 $52.60 $54.70 125 109
Mar 08, 2021 $52.30 $53.80 $50.80 $51.20 111 852
Mar 05, 2021 $52.00 $52.90 $47.80 $52.20 204 069
Mar 04, 2021 $56.50 $57.35 $51.00 $51.30 238 102
Mar 03, 2021 $55.90 $57.70 $55.20 $56.00 139 317
Mar 02, 2021 $59.30 $59.65 $56.60 $56.70 104 162
Mar 01, 2021 $57.30 $60.20 $57.30 $59.10 140 527
Feb 26, 2021 $54.00 $59.40 $52.75 $56.70 253 737
Feb 25, 2021 $54.20 $55.65 $52.30 $53.70 173 105
Feb 24, 2021 $52.80 $56.50 $52.80 $54.70 129 208
Feb 23, 2021 $53.65 $54.50 $49.60 $52.70 292 674
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT